ATE375977T1 - Sulfonamidderivate zur behandlung von krankheiten - Google Patents
Sulfonamidderivate zur behandlung von krankheitenInfo
- Publication number
- ATE375977T1 ATE375977T1 AT05702252T AT05702252T ATE375977T1 AT E375977 T1 ATE375977 T1 AT E375977T1 AT 05702252 T AT05702252 T AT 05702252T AT 05702252 T AT05702252 T AT 05702252T AT E375977 T1 ATE375977 T1 AT E375977T1
- Authority
- AT
- Austria
- Prior art keywords
- diseases
- treatment
- sulfonamide derivatives
- sulfonamide
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04290169 | 2004-01-22 | ||
| GB0406387A GB0406387D0 (en) | 2004-03-22 | 2004-03-22 | Sulfonamide derivatives for the treatment of diseases |
| US60026004P | 2004-08-09 | 2004-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE375977T1 true ATE375977T1 (de) | 2007-11-15 |
Family
ID=36954179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05702252T ATE375977T1 (de) | 2004-01-22 | 2005-01-12 | Sulfonamidderivate zur behandlung von krankheiten |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US7244766B2 (de) |
| EP (1) | EP1708991B1 (de) |
| JP (1) | JP4020954B2 (de) |
| AP (1) | AP2359A (de) |
| AR (1) | AR047509A1 (de) |
| AT (1) | ATE375977T1 (de) |
| AU (1) | AU2005214153B2 (de) |
| BR (1) | BRPI0507085A (de) |
| CA (1) | CA2553789C (de) |
| DE (1) | DE602005002930T2 (de) |
| DK (1) | DK1708991T3 (de) |
| DO (1) | DOP2005000006A (de) |
| EA (1) | EA011167B1 (de) |
| ES (1) | ES2293530T3 (de) |
| GE (1) | GEP20094781B (de) |
| MY (1) | MY143390A (de) |
| NL (1) | NL1028087C2 (de) |
| NO (1) | NO20062983L (de) |
| NZ (1) | NZ548318A (de) |
| OA (1) | OA13362A (de) |
| PA (1) | PA8622001A1 (de) |
| PE (1) | PE20051136A1 (de) |
| PL (1) | PL1708991T3 (de) |
| PT (1) | PT1708991E (de) |
| RS (1) | RS50561B (de) |
| SI (1) | SI1708991T1 (de) |
| TW (1) | TWI341831B (de) |
| UA (1) | UA84048C2 (de) |
| UY (1) | UY28721A1 (de) |
| WO (1) | WO2005080313A2 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1708991E (pt) * | 2004-01-22 | 2007-12-14 | Pfizer | Derivados de sulfonamida para o tratamento de doenças |
| GB0425054D0 (en) * | 2004-03-23 | 2004-12-15 | Pfizer Ltd | Formamide derivatives for the treatment of diseases |
| GT200500281A (es) | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
| EP1695973A1 (de) * | 2005-02-24 | 2006-08-30 | Neuro3D | Ocaperidonsalz und dieser enthaltende pharmazeutische Zubereitung |
| RU2008101897A (ru) * | 2005-07-18 | 2009-07-27 | Пфайзер Лимитед (GB) | Способ получения сульфонамидных производных |
| RU2442771C2 (ru) | 2005-08-08 | 2012-02-20 | Арджента Дискавери Лтд | Производные бицикло[2,2,1]гепт-7-иламина и их применения |
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
| PE20080361A1 (es) | 2006-04-21 | 2008-06-03 | Novartis Ag | Compuestos derivados de purina como activadores del receptor de adenosina a2a |
| JP4948913B2 (ja) * | 2006-06-16 | 2012-06-06 | 上野製薬株式会社 | ナフタレンカルボン酸アミドの製造方法 |
| KR20100113557A (ko) | 2008-01-11 | 2010-10-21 | 노파르티스 아게 | 키나제 억제제로서의 피리미딘 |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| EP2379507B1 (de) | 2008-12-30 | 2013-10-16 | Pulmagen Therapeutics (Inflammation) Limited | Sulfonamidverbindungen zur Behandlung von Atemwegserkrankungen |
| SG175738A1 (en) | 2009-05-29 | 2011-12-29 | Pfizer Ltd | Novel glucocorticoid receptor agonists |
| WO2010150014A1 (en) | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | 5r- 5 -deuterated glitazones for respiratory disease treatment |
| JP5801997B2 (ja) | 2009-07-07 | 2015-10-28 | ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ | 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器 |
| GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
| GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
| GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
| WO2011098746A1 (en) | 2010-02-09 | 2011-08-18 | Pulmagen Therapeutics (Inflammation) Limited | Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone |
| GB201002243D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| GB201002224D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| UY33597A (es) | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
| KR20140014184A (ko) | 2011-02-25 | 2014-02-05 | 아이알엠 엘엘씨 | Trk 억제제로서의 화합물 및 조성물 |
| WO2013021309A1 (en) | 2011-08-11 | 2013-02-14 | Pfizer Limited | Intermediate and process for the preparation of a sulfonamide derivative |
| WO2021260441A1 (en) | 2020-06-26 | 2021-12-30 | Mylan Pharma Uk Limited | Formulations including 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US229058A (en) * | 1880-06-22 | spencer | ||
| US143034A (en) * | 1873-09-23 | Improvement in rocking-grates | ||
| US4404224A (en) | 1981-12-02 | 1983-09-13 | American Cyanamid Company | Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals |
| US4540581A (en) | 1984-01-31 | 1985-09-10 | Bristol-Myers Company | Topical nonsteroidal anti-inflammatory compositions and uses |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| US5264067A (en) | 1992-04-23 | 1993-11-23 | Geber Garment Technology, Inc. | Adjustable length carriage compatible for use with differing spreading table widths and types |
| US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| JPH10218861A (ja) | 1997-02-04 | 1998-08-18 | Yamanouchi Pharmaceut Co Ltd | 新規なフェネタノール誘導体又はその塩 |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| WO1999000372A1 (fr) | 1997-06-27 | 1999-01-07 | Fujisawa Pharmaceutical Co., Ltd. | Sulfamides et leur utilisation medicale |
| US6362371B1 (en) | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
| US20020143034A1 (en) * | 1998-12-30 | 2002-10-03 | Fujisawa Pharmaceutical Co. Ltd. | Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| AUPQ841300A0 (en) | 2000-06-27 | 2000-07-20 | Fujisawa Pharmaceutical Co., Ltd. | New aminoalcohol derivatives |
| US6465501B2 (en) | 2000-07-17 | 2002-10-15 | Wyeth | Azolidines as β3 adrenergic receptor agonists |
| HRP20000765A2 (en) | 2000-11-10 | 2002-06-30 | Pliva D D | Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release |
| US7048994B2 (en) | 2001-02-23 | 2006-05-23 | Teijin Limited | Laminated polyester film and magnetic recording medium |
| US20030229058A1 (en) * | 2001-11-13 | 2003-12-11 | Moran Edmund J. | Aryl aniline beta2 adrenergic receptor agonists |
| DE10244972B4 (de) * | 2002-03-26 | 2013-02-28 | The Japan Steel Works, Ltd. | Wärmefester Stahl und Verfahren zur Herstellung desselben |
| EP1507754A1 (de) * | 2002-05-28 | 2005-02-23 | Theravance, Inc. | Alkoxy aryl beta-2 adrenergen rezeptoragonisten |
| EP1477167A1 (de) * | 2003-05-15 | 2004-11-17 | Pfizer Limited | [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivative als beta2 agonist |
| PT1708991E (pt) * | 2004-01-22 | 2007-12-14 | Pfizer | Derivados de sulfonamida para o tratamento de doenças |
-
2005
- 2005-01-12 PT PT05702252T patent/PT1708991E/pt unknown
- 2005-01-12 JP JP2006550327A patent/JP4020954B2/ja not_active Expired - Fee Related
- 2005-01-12 ES ES05702252T patent/ES2293530T3/es not_active Expired - Lifetime
- 2005-01-12 AT AT05702252T patent/ATE375977T1/de active
- 2005-01-12 CA CA2553789A patent/CA2553789C/en not_active Expired - Fee Related
- 2005-01-12 RS RSP-2007/0488A patent/RS50561B/sr unknown
- 2005-01-12 WO PCT/IB2005/000086 patent/WO2005080313A2/en not_active Ceased
- 2005-01-12 UA UAA200608227A patent/UA84048C2/ru unknown
- 2005-01-12 PL PL05702252T patent/PL1708991T3/pl unknown
- 2005-01-12 NZ NZ548318A patent/NZ548318A/en not_active IP Right Cessation
- 2005-01-12 DK DK05702252T patent/DK1708991T3/da active
- 2005-01-12 GE GEAP20059536A patent/GEP20094781B/en unknown
- 2005-01-12 OA OA1200600234A patent/OA13362A/en unknown
- 2005-01-12 DE DE602005002930T patent/DE602005002930T2/de not_active Expired - Lifetime
- 2005-01-12 AU AU2005214153A patent/AU2005214153B2/en not_active Ceased
- 2005-01-12 BR BRPI0507085-6A patent/BRPI0507085A/pt not_active IP Right Cessation
- 2005-01-12 AP AP2006003669A patent/AP2359A/xx active
- 2005-01-12 EP EP05702252A patent/EP1708991B1/de not_active Expired - Lifetime
- 2005-01-12 EA EA200601223A patent/EA011167B1/ru not_active IP Right Cessation
- 2005-01-12 SI SI200530103T patent/SI1708991T1/sl unknown
- 2005-01-18 MY MYPI20050197A patent/MY143390A/en unknown
- 2005-01-18 TW TW094101443A patent/TWI341831B/zh not_active IP Right Cessation
- 2005-01-19 US US11/038,452 patent/US7244766B2/en not_active Expired - Fee Related
- 2005-01-19 UY UY28721A patent/UY28721A1/es not_active Application Discontinuation
- 2005-01-20 AR ARP050100205A patent/AR047509A1/es unknown
- 2005-01-20 PE PE2005000079A patent/PE20051136A1/es not_active Application Discontinuation
- 2005-01-20 DO DO2005000006A patent/DOP2005000006A/es unknown
- 2005-01-21 PA PA20058622001A patent/PA8622001A1/es unknown
- 2005-01-21 NL NL1028087A patent/NL1028087C2/nl not_active IP Right Cessation
-
2006
- 2006-06-27 NO NO20062983A patent/NO20062983L/no not_active Application Discontinuation
-
2007
- 2007-07-03 US US11/772,995 patent/US7528170B2/en not_active Expired - Fee Related
-
2009
- 2009-04-08 US US12/420,206 patent/US7767715B2/en not_active Expired - Fee Related
-
2010
- 2010-07-01 US US12/828,762 patent/US8013019B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE369333T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| ATE375977T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| DE602005007717D1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
| DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| DE602004028763D1 (de) | Te zur behandlung von virenerkrankungen | |
| ATE512663T1 (de) | Kombination zur behandlung von erkrankungen mit zellproliferation | |
| DE602005026984D1 (de) | Chinolin-derivate zur behandlung von latenter tuberkulose | |
| EP1755661A4 (de) | Verwendung von gelsolin zur behandlung von infektionen | |
| DE60303238D1 (de) | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten | |
| ATE527241T1 (de) | Pyridiazinonderivate zur behandlung von tumoren | |
| ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| EP1732484A4 (de) | Ophthalmisches implantat zur behandlung von glaukom | |
| ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
| ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
| DE602005017503D1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
| ATE443704T1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| EP1965827A4 (de) | Behandlung von entmyelinisierenden erkrankungen | |
| DE602007009877D1 (de) | Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen | |
| ATE525355T1 (de) | 1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1 | |
| ATE482709T1 (de) | Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
| ATE504297T1 (de) | Visnadin zur behandlung von kopfhautjucken | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| ATE526970T1 (de) | Behandlung von mastitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1708991 Country of ref document: EP |